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Regulated intramembrane proteolysis (RIP)
of endoplasmic reticulum (ER) membrane-
anchored transcription factors is known to
maintain sterol homeostasis and to medi-
ate the unfolded protein response (UPR).
Here, we identified CREBH as a RIP-regu-
lated liver-specific transcription factor that
is cleaved upon ER stress and required to
activate expression of acute phase re-
sponse (APR) genes. Proinflammatory cy-
tokines increase expression of ER mem-
brane-anchored CREBH. In response to
ER stress, CREBH is cleaved by site-1 and
site-2 proteases to liberate an amino-termi-
nal fragment that transits to the nucleus to
activate transcription of the genes encod-
ing serum amyloid P-component (SAP)
andC-reactive protein (CRP). Proinflamma-
tory cytokines and lipopolysaccharide acti-
vate the UPR and induce cleavage of
CREBH in the liver in vivo. Together, our
studies delineate a molecular mechanism
for activation of an ER-localized transcrip-
tion factor, CREBH, and reveal an unprece-
dented link by which ER stress initiates an
acute inflammatory response.
INTRODUCTION
Regulated intramembrane proteolysis (RIP) is the process by
which transmembrane proteins are cleaved to release cyto-
solic domains that enter the nucleus to regulate gene tran-
scription (Brown et al., 2000). A paradigm for RIP is the pro-cessing of the sterol regulatory-element binding proteins
(SREBP-1, 2, and 1c), transcription factors that activate
genes encoding functions that regulate the synthesis of cho-
lesterol and fatty acids and cellular uptake of lipoproteins
(Brown and Goldstein, 1997). Newly synthesized SREBP is
inserted into the ER membrane via two transmembrane seg-
ments in a hairpin fashion. When cholesterol levels in the
membrane are high, SREBP is retained in the ER in a com-
plex with the polytopic sterol-sensing transmembrane pro-
tein SCAP (SREBP cleavage-activating protein) (Sakai
et al., 1998a; Matsuda et al., 2001). When cholesterol levels
decrease, the SREBP-SCAP complex dissociates from the
ER retention protein INSIG and transits to the Golgi, where
SREBP is sequentially cleaved at two sites by S1P and
S2P (Sakai et al., 1996; Feramisco et al., 2005). The amino
(N)-terminal cleaved SREBP fragment traffics to the nucleus
to activate transcription of genes required for sterol biosyn-
thesis (Sakai et al., 1996).
In addition to SREBP, another ER-resident transcription
factor, ATF6, was identified and is regulated by RIP in re-
sponse to ER stress to activate the unfolded protein re-
sponse (UPR) (Haze et al., 1999; Ye et al., 2000; Shen
et al., 2002). ATF6 is a type II ER transmembrane protein
that contains a basic leucine zipper (bZip) domain in the cy-
tosol and a stress-sensing domain in the ER lumen (Haze
et al., 1999). Under normal conditions, ATF6 is retained in
the ER through interaction with the ER protein chaperone
BiP/GRP78 (Shen et al., 2002). Upon accumulation of un-
folded or misfolded proteins in the ER lumen, ATF6 is re-
leased from BiP and transits to the Golgi compartment,
where it is cleaved by S1P and S2P in a manner similar to
SREBPs (Ye et al., 2000). The cleaved ATF6 cytosolic do-
main traffics to the nucleus to activate transcription of UPR
target genes.
Recently, researchers identified several new members of
the membrane bound transcription factor family that are
structurally similar to ATF6. These new members, including
Luman, OASIS, and CREBH, all possess a transcription ac-
tivation domain, a bZip domain in close proximity to a hydro-
phobic transmembrane domain, and a domain that residesCell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc. 587
Figure 1. Induction of CREBH mRNA during Fetal Liver Development and upon Proinflammatory Cytokines
(A) Structural comparison of CREBH and ATF6. The domains are indicated by residue numbers of amino acids.
(B–D) Northern blot analysis of CREBH mRNA levels in tissue samples from 3-month-old wild-type C57BL/6J mice (B), in fetal livers during embryogenesis
(C), and in H2.35 cells treated with 40 ng/ml IL6 (D). For panels (B–D), representative data from at least three independent experiments is presented.in the ER lumen (Omori et al., 2001; Raggo et al., 2002; Chin
et al., 2005; Kondo et al., 2005). CREBH was identified as
a hepatocyte-specific bZip transcription factor belonging to
the cyclic AMP response element binding protein transcrip-
tion factor (CREB/ATF) family (Omori et al., 2001). Recent re-
ports suggested that CREBH requires proteolytic cleavage
for its activation (Omori et al., 2001; Chin et al., 2005). How-
ever, the stimuli that activate CREBH, the mechanism of
CREBH cleavage, and the physiological role that CREBH
provides in the liver are unknown.
The innate immune response is an ancient metazoan
adaptation mechanism initiated by chemical structures pre-
sented by invading microorganisms or revealed by damage
to the host. The systemic inflammatory component of innate
immunity is called the acute phase response (APR) (Gabay
and Kushner, 1999; Medzhitov and Janeway, 2002; Yoo
and Desiderio, 2003). In this study, we use in vitro and
in vivo analyses to delineate the molecular mechanism gov-
erning stimulus-induced activation of CREBH and its biolog-
ical role in activation of an acute inflammatory response.
RESULTS
CREBH Is Expressed in Fetal Liver from Mid-to-Late
Embryonic Stage and Is Induced by Proinflammatory
Cytokines
A CREBH homolog was previously identified in C. elegans as
a novel ER stress-responsive gene encoding a bZip tran-
scription factor (Shen et al., 2005). CREBH has a predicted
structure similar to that of ATF6 and Luman (Omori et al.,
2001; Raggo et al., 2002) (Figure 1A). However, in contrast
to ATF6, CREBH expression is strictly restricted to liver tis-
sue (Omori et al., 2001) (Figure 1B). During embryogenesis,588 Cell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc.CREBH expression is first detected at gestation stage E12
(Figure 1C). In murine H2.35 hepatoma cells, CREBH
mRNA was induced in a time-dependent manner upon treat-
ment with IL6, IL1b, or TNFa (Figures 1D and S1A). In addi-
tion, ER stress inducers dithiothreitol (DTT), thapsigargin
(Tg), and Brefeldin A (BFA), all known to activate the UPR
as well as NF-kB to stimulate production of proinflammatory
cytokines (Kaufman, 1999), also significantly induced tran-
scription of CREBH mRNA (Figures S1A–S1C). In contrast,
tunicamycin (Tm), a drug that blocks asparagine (N)-linked
glycosylation and thus induces the UPR, had a minor effect
on induction of CREBH mRNA in H2.35 and HepG2 hepa-
toma cells (Figures S1A–S1C). These results suggest that
proinflammatory cytokines are strong inducers for CREBH
mRNA expression in hepatocytes.
ER Stress Induces Cleavage of CREBH to Release
an N-Terminal Fragment that Transits to the Nucleus
CREBH displays a high degree of sequence conservation
within the putative transmembrane domains and a portion
of the lumenal domains of RIP-regulated ER-localized pro-
teins (Ye et al., 2000) (Figure 2A). To test whether CREBH
is subject to cleavage for its activation, we stably expressed
an N-terminal flag-tagged CREBH protein in H2.35 cells.
Upon treatment with BFA, a reagent that induces ER stress
by collapse of the Golgi into the ER, CREBH was cleaved to
release a 50 kDa N-terminal fragment (Figure 2B, lane 3).
Moreover, ER stress inducers including DTT, Tm, and Tg all
significantly induced CREBH cleavage to release a 50 kDa
N-terminal fragment (Figure 2B, lanes 7–9). Although IL6
and TNFa strongly induced expression of the CREBH
mRNA (Figures 1D and S1), they did not significantly induce
CREBH cleavage in transfected H2.35 cells (Figure 2B).
Figure 2. ER Stress Induces Cleavage of CREBH to Release its N-Terminal Fragment that Transits into the Nucleus
(A) Alignment of transmembrane and lumenal domains of SREBP, ATF6, Luman, and CREBH in human (hs) and mouse (mm).
(B) ER stress induces CREBH cleavage in H2.35 cells. H2.35 cells stably expressing flag-tagged human CREBH were treated with 0.5 mg/ml BFA, 20 ng/ml
TNFa, 40 ng/ml IL6, 5 mM DTT, 0.5 mM Tg or 5 mg/ml Tm for 8 hr. Untransfected H2.35 cells (lane 1) and H2.35 cells expressing human CREBH (lane 2) were
included as controls. Western blot analyses were performed using an anti-flag monoclonal antibody (upper panel) and a-actin antibody (lower panel).
(C) Tm induces cleavage and translocation of CREBH in H2.35 cells. The H2.35 cells stably expressing flag-tagged CREBH were cultured with or without Tm
(5 mg/ml) for 4, 8, or 12 hr. Membrane and nuclear fractions were prepared for Western blot analysis.
(D) CREBH transits to the nucleus upon ER stress. COS7 cells were cotransfected with a construct expressing flag-tagged full-length CREBH (CREBH-F) or
CREBH-DC (green fluorescence) and a construct expressing KDEL-RFP (red fluorescence), and they were cultured with or without Tm (5 mg/ml) for 4 hr.
Cells were stained with FITC-conjugated anti-flag antibody and subjected to Zeiss Confocal Microscope analysis. Magnification: 40  10.These results suggest that CREBH cleavage is activated by
ER stress.
Cell fractionation experiments demonstrated that in the
absence of ER stress, the 75 kDa full-length CREBH protein
(CREBH-F) was detected exclusively in the membrane
fraction, similar to calnexin, a transmembrane molecular
chaperone localized to the ER (Figure 2C). When the cells
were treated with Tm, the 50 kDa cleaved CREBH fragment
gradually increased with time and was exclusively detected
in the nuclear fraction, similar to the nuclear protein, poly-
ADP ribose polymerase (PARP) (Figure 2C). These results
suggest that cleavage of CREBH upon ER stress produces
a nuclear form of CREBH (CREBH-N). Note that CREBH
protein expressed in transfected cells migrated with a mo-
lecular mass of approximately 75 kDa, larger than 51 kDa,
which was predicted from its amino acid sequence. This
may be due to posttranslational phosphorylation and/orglycosylation that are observed in other bZip transcription
factors of ATF/CREB family (Shaywitz and Greenberg,
1999).
CREBH translocation was confirmed by confocal immu-
nofluorescence microscopy analysis. In the absence of ER
stress, CREBH expressed in COS7 cells displayed a fine re-
ticular localization around the nucleus that colocalized with
the ER (Figure 2D). When cells were treated with Tm for
4 hr, a significant portion of the immunoreactive CREBH pro-
tein accumulated in the nucleus (Figure 2D). In addition, a
C-terminal CREBH deletion mutant (CREBH-DC) that lacks
the putative transmembrane and lumenal domains but con-
tains the trans-activation and the bZip domains exclusively
localized to the nucleus (Figure 2D). These results support
the idea that ER-localized CREBH is cleaved upon ER stress
to release its N-terminal portion that translocates to the
nucleus.Cell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc. 589
CREBH Is Cleaved by S1P and S2P Proteases
in Response to ER Stress
Alignment CREBH, SREBP, ATF6, and Luman protein se-
quences revealed a conserved RR sequence and an
R  L sequence located in the lumenal domain of CREBH
at sites of 14 and 18 residues from the transmembrane do-
main, respectively (Figure 2A). These motifs are hallmarks for
S1P recognition (Cheng et al., 1999; Toure et al., 2000). Fur-
thermore, CREBH has a proline in its hydrophobic trans-
membrane domain at a location similar to the conserved
proline for S2P cleavage identified in SREBP and ATF6 (Ye
et al., 2000). To test the potential for S1P to cleave CREBH,
flag-tagged CREBH was coexpressed with an ER-localized
version of S1P, S1P-KDEL, in COS7 cells. As an additional
control, full-length CREBH was expressed with S1P-
KDAS, which is not retrieved to the ER and does not cleave
SREBP or ATF6 (DeBose-Boyd et al., 1999). Whereas only
a minor portion of full-length CREBH was cleaved in the
presence of S1P-KDAS (Figure 3A, lanes 4 and 5), expres-
sion of S1P-KDEL induced substantial cleavage of full-length
CREBH, generating an N-terminal product that comigrated
with the 50 kDa CREBH product induced by BFA treatment
(Figure 3A, lanes 3, 6, and 7) and with CREBH-DC, the
CREBH cyotosolic fragment that lacks the putative trans-
membrane and lumenal domains and localizes to the nu-
cleus (Figure 3A, lane 1; Figure 2D). Here, we define
CREBH-DC as a nuclear form of CREBH (CREBH-N).
To test the requirement for S1P and S2P in CREBH pro-
cessing, we examined cleavage of CREBH in wild-type
(K1), S1P-deficient (SRD-12B), and S2P-deficient (M19) Chi-
nese hamster ovary (CHO) cells (Rawson et al., 1997, 1998).
Different from stably transfected H2.35 cells (Figure 2B), K1
cells transiently transfected with the CREBH expression vec-
tor exhibited a small amount of cleaved CREBH in nuclear
fraction in the absence of Tm treatment (Figure 3B, lane 2).
This cleavage may be due to ER stress resulting from over-
production of flag-tagged CREBH, a similar phenomenon
that was observed for ATF6 (Ye et al., 2000; Nadanaka
et al., 2004). After Tm treatment, the nuclear form of CREBH
increased approximately 6-fold in K1 cells (Figure 3B, lane 3).
By comparison, M19 cells did not produce a nuclear form of
CREBH in the absence or presence of Tm. However,
a cleaved intermediate (CREBH-I) was detected in the mem-
brane fraction of M19 cells, which might result from cleavage
at the S1P site (Figure 3B, lanes 5 and 6). Complementation
of the M19 defect by expression of wild-type S2P restored
CREBH processing in M19 cells (Rawson et al., 1997) (Fig-
ure 3B, lane 7). In SRD-12B cells, production of the cleaved
CREBH was decreased in the absence or presence of
ER stress, compared to that in K1 cells (Figure 3B, lanes
9–11). Expression of wild-type S1P in SRD-12B cells sig-
nificantly increased production of the cleaved CREBH in
response to ER stress (Sakai et al., 1998b) (Figure 3B, lane
11). In addition, small amounts of alternatively cleaved
forms of CREBH were observed in the membrane fraction
of SRD-12B cells (Figure 3B, lanes 9 and 10), suggesting
alternative processing may occur in the absence of S1P
cleavage.590 Cell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc.We next tested whether the central Arg, R361, within the
RRL motif is required for S1P-mediated cleavage by
replacing R361 with Ala (R361A). Compared to cells that ex-
press wild-type CREBH, production of the nuclear form of
CREBH was reduced in the cells that express a R361A mu-
tant CREBH in the presence of ER stress (Figure 3C, lane 4),
suggesting that R361 is a residue required for efficient cleav-
age of CREBH by S1P.
CREBH Acts on the UPRE but Not on the ERSE
Since ER stress induces cleavage of CREBH, we tested
whether CREBH serves as a UPR transcriptional activator.
In mammalian cells, UPR transcriptional induction is medi-
ated through a cis-acting ER stress-response element
(ERSE: CCAAT-N9-CCACG) in the promoter regions of re-
sponsive genes (Yoshida et al., 1998). The promoter of the
ER stress-response gene BiP contains three tandem copies
of the ERSE motif. Therefore, we determined whether
CREBH contributes to the UPR by analysis of luciferase ex-
pression under control of the BiP promoter. As positive con-
trols, full-length ATF6 (ATF6 p90) activated expression of lu-
ciferase from the BiP/ERSE reporter after ER stress, and the
cleaved ATF6 (ATF6 p50) activated the reporter to a greater
extent (Figure 3D). In contrast, full-length CREBH (CREBH-F)
or the nuclear form (CREBH-N) did not significantly increase
expression of luciferase from the ERSE reporter (Figure 3D).
This result is consistent with the Western blot analysis show-
ing that expression of endogenous ER chaperones BiP and
GRP94 (Figure S1D) as well as calreticulin, Erp72, and pro-
tein disulfide isomerase (data not shown) was not affected
by overexpression of CREBH-N, suggesting that CREBH
does not serve as a UPR trans-activator for expression of
classic ER chaperone genes.
We then tested the effect of CREBH on another ER stress-
response cis-acting element, the UPR element (UPRE),
which has the sequence TGACGTGG/A (Yoshida et al.,
1998; Wang et al., 2000). Upon Tm treatment, CREBH-F ac-
tivated the UPRE reporter by more than 10-fold relative to
that of the control (Figure 3E). CREBH-N activated expres-
sion from the UPRE reporter by approximately 18-fold
(Figure 3E). Note that CREBH-F activated expression from
the UPRE reporter by approximately 2-fold relative to that
of the control in the absence of Tm. This effect may be due
to cleavage of CREBH caused by overexpression of
CREBH-F (Figure 3B). Together, these results suggest that
CREBH may modulate transcriptional induction of some
ER stress-response genes that contain UPRE sequences
in their promoter regions, although CREBH does not act as
a typical UPR trans-activator like ATF6 or XBP1.
To demonstrate the requirement of S1P- and S2P-medi-
ated cleavage for CREBH activation and function in re-
sponse to ER stress, we analyzed trans-activation effects
of CREBH on expression of the UPRE reporter in S1P- or
S2P-deficient CHO cells. In contrast to wild-type cells,
CREBH-F had a minor effect on activation of the UPRE re-
porter in S1P- or S2P-deficient CHO cells, even after Tm
treatment (Figure 3F). However, expression of the nuclear/
cleaved form of CREBH efficiently activated the UPRE
Figure 3. CREBH Is Cleaved by S1P and S2P upon ER Stress
(A) CREBH is cleaved by S1P-KDEL but not by S1P-KDAS. CREBH construct DNA (1mg) was mixed with S1P-KDEL or S1P-KDAS construct DNA (1 or 2 mg
as indicated) for transfection of COS7 cells in one well of a 6-well plate. Cells expressing CREBH-F were cultured with 0.5 mM BFA for 8 hr (lane 3). CREBH
was detected by Western blot analysis using an anti-flag antibody.
(B) Cleavage of CREBH requires S1P and S2P. Wild-type (K1), S2P-deficient (M19), and S1P-deficient (SRD-12B) CHO cells were transfected with con-
struct expressing flag-tagged full-length CREBH and were cultured with or without 5 mg/ml Tm for 10 hr. Membrane and nuclear fractions were prepared for
Western blot analysis using an anti-flag antibody. Nontransfected cells were included as controls (lanes 1, 4, and 8).
(C) Cleavage of CREBH mutant R361A is decreased upon ER stress. COS7 cells were transfected with construct expressing flag-tagged wild-type CREBH
or mutant CREBH (R361A), and they were cultured with or without Tm for 10 hr.
(D) CREBH does not activate transcription from the ERSE motif. COS7 cells in one well of 6-well plate were cotransfected with the CREBH or ATF6 expres-
sion vector (0.2 mg), an ERSE-luciferase reporter construct (0.5 mg), and pCDNA3-lacZ (0.2 mg), and they were cultured with or without 5 mg/ml Tm for 10 hr.
Each bar denotes the mean ± S.D.
(E) CREBH activates transcription from the UPRE motif. Conditions for transfection and treatment of COS7 cells for the UPRE reporter assay were the same
as those described in (D).
(F) Full-length CREBH requires S1P- and S2P-mediated cleavage to activate the UPRE reporter. Conditions for transfection and treatment of K1, SRD-12B,
or M19 CHO cells for the UPRE reporter assay were the same as those described in (D).reporter in S1P- and S2P-deficient CHO cells (Figure 3F), in-
dicating that both S1P- and S2P-mediated cleavages are re-
quired for full-length CREBH to elicit its transcriptional activ-
ity upon ER stress.
CREBH Is Required to Induce Expression of Serum
Amyloid P-Component and C-Reactive Protein
To explore the physiological function of CREBH, we silenced
the CREBH gene in the mouse by using a lentivirus-basedsystem that expresses CREBH-specific hairpin small in-
terfering RNAs (siRNAs) (Rubinson et al., 2003). CREBH-
specific RNAi lentivirus was injected into single-cell mouse
embryos to generate CREBH-knockdown mice. Empty vec-
tor lentivirus was also injected into single-cell mouse em-
bryos as a control. The mice were screened by examining
expression of CREBH and green fluorescence protein (GFP),
a marker for expression from the lentiviral vector. CREBH
siRNA specifically targeted and degraded CREBH mRNACell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc. 591
Figure 4. CREBH Is Required to Upregulate Expression of the CRP and SAP Genes
(A) Identification of CREBH knockdown mice. Total RNAs were isolated from the livers of the CREBH RNAi or the control RNAi mice and subjected to North-
ern blot analysis for detecting levels of GFP mRNA and CREBH mRNA, respectively.
(B) Morphology of CREBH knockdown embryos at gestation stage E14.5. The paraffin-embedded embryo sections were stained with hematoxylin and
eosin. Magnification: 20.
(C) Northern blot analysis of levels of CREBH, CRP, and SAP mRNA in the livers of the CREBH knockdown or the control mice.
(D and E) SAP and CRP induction requires CREBH. CREBH knockdown and control RNAi mice at 3 months of age were challenged with IL6 (25 ng/gram
body weight) plus IL1b (25 ng/gram body weight), LPS (3 mg/gram body weight), or Tm (2 mg/kg body weight). Serum levels of SAP and CRP in the mice
were determined before injection and at 24 hr after injection. Data points are serum levels of SAP or CRP for individuals, n = 5 CREBH knockdown or 5
control RNAi mice per injection. The differences in CREBH knockdown and control mice are statistically significant (p < 0.001). CTL, control RNAi mice;
KD, CREBH knockdown mice.in the livers of the knockdown mice (Figure 4A). Although
previous studies suggested that CREBH activated the pro-
moter of the gene encoding hepatic gluconeogenic enzyme
phosphoenolpyruvate carboxykinase (Chin et al., 2005), his-
topathological analysis of the CREBH knockdown embryos
at E14.5 did not reveal any morphological or developmental
defects (Figure 4B).
To identify potential target genes for CREBH action in the
liver, we performed gene chip analysis of RNA samples from
CREBH knockdown or control fetal livers at gestation stage
E14.5. At this time in embryogenesis, the CREBH gene is592 Cell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc.highly expressed (Figure 1C). Expression of genes involved
in the APR and lipid metabolism was affected by knockdown
of the CREBH gene in the fetal liver (data not shown). North-
ern blot and quantitative real-time RT-PCR analyses con-
firmed that expression of mRNAs encoding C-reactive pro-
tein (CRP) and its structural homolog pentraxin, serum
amyloid P-component (SAP), was significantly reduced in
the fetal livers of the CREBH knockdown mice compared
to the RNAi control mice (Figure 4C). Additionally, expression
of mRNAs encoding serum amyloid A3 (SAA3) and apolipo-
protein B-100 (ApoB) was reduced 3- to 5-fold in the CREBH
knockdown mice compared to that of the control (Fig-
ure S2A). In contrast, mRNA levels of other major APR pro-
teins, including serum amyloid A 1 (SAA1), serum amyloid
A2 (SAA2), fibrinogen, and a1-acid glycoprotein in CREBH
knockdown fetal livers, were similar to those in the control fe-
tal livers (Figure S2B).
In mice, both SAP and CRP are inducible by stimulation
with proinflammatory cytokines or bacterial LPS (Ochrietor
et al., 2000). The reduced mRNA levels of CRP and SAP in
CREBH knockdown mice suggested that CREBH might be
required to activate the APR. To test this hypothesis, we
examined the response of CREBH knockdown mice to stim-
uli of inflammatory cytokines, LPS, or Tm, respectively. The
basal serum levels of SAP and CRP in the CREBH knock-
down mice were detectable but lower than those in the con-
trol RNAi mice (Figures 4D and 4E). At 24 hr after injection of
IL6 plus IL1b or LPS, serum levels of SAP in the control RNAi
mice were significantly increased to a level of approximately
4.5 and 9 times that of the untreated control mice, respec-
tively (Figure 4D). In contrast, serum levels of SAP in the
CREBH knockdown mice were only slightly increased after
IL6 plus IL1b or LPS challenge (Figure 4D). Injection of Tm
increased serum levels of SAP in the control mice approxi-
mately 12-fold, whereas Tm injection increased serum SAP
in the CREBH knockdown mice approximately 2-fold (Fig-
ure 4D). Furthermore, while injection of proinflammatory
cytokines, LPS, or Tm increased serum levels of CRP ap-
proximately 2-fold in control RNAi mice, there was no such
increase in the treated CREBH knockdown mice (Figure 4E).
These results support the hypothesis that CREBH is required
to potently activate transcription of the SAP and CRP genes
in response to ER stress as well as proinflammatory cyto-
kines in vivo. In addition, although expression of the SAA3
mRNA in the CREBH knockdown fetal liver was reduced
(Figure S2A), induction of serum SAA3 was not significantly
reduced in the CREBH knockdown mice in response to
these stimuli (data not shown), suggesting that induction of
not all APR genes requires CREBH during the APR.
ER Stress Activates Both the UPR and the APR,
and Proinflammatory Cytokines Induce ER Stress
and Cleavage of CREBH in the Liver
The finding that cleavage of CREBH is induced by ER stress
to activate expression of the APR genes raises an intriguing
notion that ER stress induces both the UPR and the APR in
hepatocytes. To confirm this, we examined the effect of ER
stress on expression of CRP and SAP in mouse primary he-
patocytes. Tm treatment increased expression of the CRP
and SAP mRNA in a time-dependent manner (Figure 5A).
This pattern of induction was similar to that observed for
UPR-mediated induction of BiP mRNA and spliced XBP1
mRNA (Kaufman, 2002). Intraperitoneal injection of Tm in-
duced expression of both the APR genes and the UPR
genes in the murine livers (Figure 5B). Furthermore, expres-
sion of a mutant human clotting factor VIII (FVIII), a secreted
protein that is folding defective (Miao et al., 2004), simulta-
neously induced the UPR and APR in the murine liver
(Figure S3A). Together, these data support the idea thatER stress induces both the UPR and the APR in hepato-
cytes.
Analysis of hepatoma cells in vitro indicated that cleavage
of CREBH is induced by ER stress but is only marginally af-
fected by proinflammatory cytokines (Figure 2B). To eluci-
date how CREBH is activated in response to proinflamma-
tory cytokines in vivo, we investigated whether IL6, IL1b, or
LPS cause ER stress and activate the UPR in the liver. At
24 hr after injection of IL6, IL1b, or LPS, the levels of
mRNA encoding ER chaperones BiP and CHOP were in-
creased 4- to 7-fold in the liver (Figures 5C and 5D). More-
over, the levels of spliced XBP1 mRNA and mRNA encoding
EDEM, an ER degradation-enhancing a-mannosidase-like
protein that is regulated by the UPR (Yoshida et al., 2003),
were also increased in the liver upon IL6, IL1b, or LPS stim-
ulation (Figures 5C and 5D). The fold-increases in these
mRNA levels were approximately 50% of those observed af-
ter injection of Tm (Figure 5E). These data suggest that proin-
flammatory cytokines and bacterial LPS can cause, at least
indirectly, UPR activation in the liver.
To test whether proinflammatory cytokines and LPS can
induce cleavage of CREBH during the APR activation, we
performed Western blot analysis of murine liver extracts
from wild-type or CREBH knockdown mice challenged
with IL6 plus Il1b, LPS, or Tm by using an anti-murine
CREBH antibody. Upon stimulation of proinflammatory cyto-
kines, LPS, or ER stress, the cleaved form of CREBH was in-
creased in the livers of wild-type mice (Figure 5F). In contrast,
CREBH protein was not detected in the livers of CREBH
knockdown mice upon the same stimulation (Figure 5G).
These results provide evidence that proinflammatory cyto-
kines and LPS induce cleavage of CREBH upon APR activa-
tion in the liver. To clarify why proinflammatory cytokines
have different effects on CREBH cleavage in hepatoma cells
and in the liver, we investigated roles of proinflammatory cy-
tokines and LPS in causing ER stress and activation of the
UPR and APR in hepatoma cells in vitro. The mRNA levels
of BiP, CHOP, EDEM, or spliced XBP1 were only marginally
changed in H2.35 cells treated with LPS or IL6 plus IL1b, in-
dicating that proinflammatory cytokines and LPS hardly in-
duce the UPR in hepatoma cells (Figure S3B). Furthermore,
the SAP and CRP mRNAs were not detectable in H2.35 and
HepG2 cells in response to proinflammatory cytokines
(Figure S3C). These results suggest that the acute inflamma-
tory response in hepatoma cell lines is impaired and not
comparable to that in the liver.
CREBH Interacts with ATF6 to Synergistically
Activate Transcription of Major APR Genes
To determine whether CREBH directly activates transcrip-
tion from the SAP and CRP promoters, we analyzed effects
of CREBH on luciferase reporter expression under control of
the 50-flanking sequence from the murine SAP gene or the
humanCRP gene in H2.35 cells. In the presence of Tm treat-
ment, full-length CREBH increased expression of luciferase
from the SAP reporter by approximately 14-fold relative
to that of the vector control (Figure 6A). In the absence or
presence of Tm treatment, the nuclear form of CREBHCell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc. 593
Figure 5. ER Stress Activates the APR in Hepatocytes, and Proinflammatory Cytokines Induce ER Stress and Cleavage of CREBH
in the Liver
(A) Tm induces expression of CRP, SAP,BiP, and spliced XBP1mRNAs. Primary hepatocytes were treated with Tm (5 mg/ml) for 2, 4, 6, and 8 hr. Total RNA
was prepared for Northern blot analysis of CRP, SAP, and BiP mRNAs (upper panel). Levels of spliced XBP1 mRNA were determined by quantitative real-
time RT-PCR (lower panel). For panels (A) and (B), experiments were performed at least three times, and representative data are shown.
(B) Tm induces expression of CRP, SAP, BiP, and spliced XBP1 mRNAs in mice liver in vivo. C57BL/6J mice at 3 months of age were injected intraperi-
toneally with Tm (2 mg/kg body weight) in 150 mM dextrose solution. Mice were injected with same volume of dextrose solution as a control. Total RNA was
prepared at 24 hr after injection.
(C–E) Proinflammatory cytokines, LPS, and Tm induce UPR and APR expression in vivo. C57Bl/6J mice at 3 months of age were intraperitoneally injected
with saline, IL6 (25 ng/gram body weight), IL1b (25 ng/gram body weight), LPS (3 mg/gram body weight), or Tm (2 mg/gram body weight). Total RNA was
prepared at 24 hr after injection for quantitative real-time RT-PCR. Fold changes of mRNA levels were determined after normalization to internal control 18S
ribosomal RNA levels. Each bar denotes the mean ± S.D.; n = five mice per injection.
(F and G) Proinflammatory cytokines, LPS, and Tm induce cleavage of endogenous CREBH. Wild-type (F) or CREBH knockdown (G) mice at 3 months of
age were intraperitoneally injected with saline (control), IL6 (25 ng/gram body weight) plus IL1b (25 ng/gram body weight), LPS (3 mg/gram body weight), or
Tm (2 mg/gram body weight). Liver protein extracts were prepared at 24 hr after injection. Full-length and cleaved CREBH were detected by Western blot
analysis using a polyclonal anti-mouse CREBH antibody. Nontransfected and CREBH-N-transfected H2.35 cells were included as controls.dramatically increased expression of the SAP reporter by
more than 16-fold, compared to the control (Figure 6A). Sim-
ilarly, expression of CREBH significantly activated expres-
sion of luciferase under control of the human CRP promoter
(Figure 6A). These results support the hypothesis that
CREBH is cleaved and activated to induce expression of
the major acute phase genes upon ER stress.
Since CREBH and ATF6 possess highly related bZip di-
merization domains and are both cleaved by the same pro-594 Cell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc.teases upon ER stress, we proposed that CREBH and ATF6
form homodimers or heterodimers to function. CREBH ho-
modimerization was first evidenced by the trans-dominant
negative effect of a truncated CREBH protein that encom-
passes only the bZip dimerization domain but lacks the tran-
scriptional activation domain (CREBH-DN). Expression of
CREBH-DN efficiently suppressed luciferase expression
from the murine SAP promoter and the human CRP pro-
moter in response to ER stress (Figure 6B). This result
Figure 6. CREBH Interacts with ATF6 to Synergistically Activate Transcription of the SAP and CRP Genes
(A) CREBH activates transcription from CRP and SAP promoters. H2.35 cells in a 35 mm collagen-coated plate were cotransfected with a control vector or
a CREBH expression vector (0.25 mg), the luciferase reporter (0.6 mg), and pCDNA3-LacZ (0.25 mg), and they were cultured with or without 5 mg/ml Tm for 10
hr. For (A, B, and D–F), each bar denotes the mean ± S.D.
(B) CREBH-DN efficiently suppresses CREBH trans-activation on the murine SAP and the human CRP promoters. H2.35 cells were cotransfected with the
luciferase reporter construct and a control vector or a vector expressing CREBH-DN, and they were then cultured with or without Tm for 10 hr.
(C) CREBH interacts with ATF6 upon ER stress. 293T cells were transfected with a control vector or a vector expressing the cleaved form of CREBH; they
were then cultured with or without Tm for 8 hr. Immunoprecipitation and Western blot analysis were performed with an anti-human ATF6 polyclonal antibody
or anti-flag antibody as indicated. CREBH expression levels were determined by Western blot analysis of total cell lysates using the anti-flag antibody (lower
panel).
(D) The nuclear forms of ATF6 or CREBH activate transcription from the SAP and CRP promoters.
(E and F) CREBH and ATF6 synergistically activate transcription from the SAP (E) and CRP promoters (F). Vector DNA (25 ng control vector, 20 ng CREBH-
and/or 25 ng ATF6-expression vector) was mixed with 100 ng reporter construct and 150 ng pcDNA3-lacZ for transfection of H2.35 cells in a 35 mm col-
lagen-coated plate.suggests that CREBH-DN can form a truncated dimer with
the activated CREBH and therefore suppress the action of
endogenous CREBH on expression of the SAP and CRP
genes. The potential for CREBH and ATF6 to form hetero-
dimers was tested by immunoprecipitation (IP)-Western
blot analysis. IP was performed using an anti-human ATF6
antibody to pull-down endogenous ATF6 protein, and West-
ern blot analysis was performed using an anti-flag antibody
to detect CREBH protein associated with ATF6. Under nor-
mal conditions, a small amount of CREBH was detected in
a complex with endogenous ATF6 (Figure 6C, lane 3). After
Tm treatment, the interaction between the cleaved forms
of CREBH and ATF6 significantly increased (Figure 6C,lane 4). Immunoprecipitation of the same cell lysates using
an anti-flag antibody and Western blot analysis using an
anti-ATF6 antibody confirmed interaction between the
cleaved ATF6 and CREBH (Figure 6C, lane 4). Together,
these results suggest that ER stress induces formation of
CREBH and ATF6 heterodimers.
To investigate the biological significance of CREBH and
ATF6 heterodimer formation, we first tested whether ATF6
can activate transcription from the murine SAP and human
CRP promoters. The cleaved form of ATF6 (ATF6 p50) in-
creased expression of luciferase under control of either the
murine SAP promoter or the human CRP promoter (Fig-
ure 6D). Moreover, the livers of mice injected with vectorCell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc. 595
expressing ATF6 p50 or CREBH-N produced higher levels of
the murine SAP mRNA compared to the livers of mice in-
jected with control vector, thus confirming activation effects
of ATF6 and CREBH on the endogenous SAP gene in vivo
(Figure S4A). We then tested whether CREBH and ATF6
act synergistically to activate transcription. Coexpression of
CREBH with ATF6 p50 significantly activated transcription
of luciferase from the SAP and CRP reporters to a greater ex-
tent than expression of either CREBH or ATF6 p50 alone
(Figures 6E and 6F). The synergistic effects of CREBH and
ATF6 on transcription from the human CRP promoter and
the UPRE were confirmed by coexpression of the cleaved
forms of CREBH and ATF6 (Figures S4B and S4C). Further-
more, expression of CREBH-DN significantly suppressed
both CREBH- and ATF6-induced reporter gene expression
in the absence or presence of ER stress (Figures 6E and
6F, S4B, and S4C). The sum of these results suggests that
CREBH and ATF6 interact with each other to synergistically
activate expression of their target genes upon ER stress.
CREBH and ATF6 Bind to a Conserved DNA
Sequence Motif Identified in the APR Genes
Analysis of protein binding sequences identified one or sev-
eral conserved sequences, containing the core nucleotides
known to bind CREB/ATF (CRE) and ATF6 (UPRE), in the
promoter regions of the mammalian CRP, SAP, and ApoB
genes (Figure 7A). To test whether CREBH and ATF6 can
bind to this conserved DNA sequence element, we per-
formed electrophoretic mobility shift assay (EMSA) by using
nuclear extract (NE) from COS1 cells overexpressing
CREBH or ATF6 and a biotin-labeled human CRP gene
probe containing the conserved DNA sequence. Binding ac-
tivity was detected with NE from COS1 cells expressing
CREBH-F in the absence of Tm (Figure 7B, lane 2). This
weak binding activity was probably due to the nuclear form
of CREBH generated by overexpression of full-length
CREBH. Tm treatment further increased the binding activity
in NE from COS1 cells expressing CREBH-F (Figure 7B, lane
3). The binding activity to the human CRP probe was signif-
icantly increased in NE from COS1 cells overexpressing
CREBH-N (Figure 7B, lane 4), and this binding activity was
competed out by adding a 200-fold excess of unlabeled hu-
man CRP DNA probe (Figure 7B, lane 5). CREBH-N did not
bind to a human CRP probe with mutation at the conserved
sequence (Figure 7B, lane 6). In addition, EMSA analysis of
membrane and nuclear extract fractions indicated that only
the nuclear/cleaved form of CREBH efficiently bound to the
human CRP probe (Figures S5A and S5B), thus providing
evidence that cleaved, not full-length, CREBH is required
to activate transcription of the specific APR genes.
To confirm specific binding of CREBH to the conserved
sequence element, we performed a DNA-Protein binding as-
say by using streptavidin-coated beads to bind the biotiny-
lated human CRP probe, which was used to interact with
NE proteins from COS1 cells expressing flag-tagged
CREBH-N and/or HA-tagged ATF6 p50. CREBH or ATF6
bound to the beads were then eluted and identified by West-
ern blot analysis. CREBH or ATF6 was detected in the NE596 Cell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc.proteins that interacted with the wild-type human CRP
probe, but not the mutant human CRP probe (Figure 7C,
lanes 3, 4, 13, and 14). Both CREBH and ATF6 were de-
tected in the DNA probe-associated NE proteins from cells
expressing both CREBH-N and ATF6 p50 (Figure 7C, lanes
7 and 15), indicating that both CREBH and ATF6 can specif-
ically bind to the same conserved element in the APR genes.
ApoB is an essential component of very low-density lipo-
protein (VLDL) and low-density lipoprotein (LDL) that is asso-
ciated with acute phase response to inflammation (Sattar
et al., 2004). Induction of the ApoB mRNA in the CREBH
knockdown fetal liver was significantly decreased compared
to that in the control mice (Figure S2A). The nuclear form of
CREBH was found to significantly activate transcription of lu-
ciferase under control of a 50 flanking sequence from the hu-
man ApoB gene (Figure S5C). Furthermore, both the human
and murine ApoB genes contain one or several CREBH/
ATF6 binding elements in their promoter regions (Figure 7A).
EMSA demonstrated that the nuclear forms of CREBH and
ATF6 bound to at least one of the conserved elements in
the human ApoB gene (Figure S5D). However, in contrast
to CRP and SAP mRNAs, induction of endogenous ApoB
mRNA in mice was only slightly increased upon Tm treat-
ment (Figure S5E), suggesting that ER stress-induced acti-
vation of CREBH may be required for, but not sufficient to
fully activate, transcription of the ApoB gene during the
APR. Whether other factors are required to function with
CREBH to induce transcription of the ApoB gene is an in-
triguing question to be elucidated.
DISCUSSION
In this study, we conclude that CREBH plays a critical role in
activation of the acute inflammatory response based on the
following findings: (1) expression of CREBH is liver specific
and is induced by proinflammatory cytokines; (2) ER stress
induces cleavage of CREBH to release an N-terminal frag-
ment that traffics to the nucleus to activate transcription;
(3) CREBH activation requires processing by Golgi-localized
proteases S1P and S2P; (4) CREBH does not contribute to
the classical UPR induction but is required for the APR by
regulating transcription of the CRP and SAP genes; (5)
CREBH and ATF6 bind to a conserved promoter element
in the specific APR genes; (6) CREBH and ATF6 interact
and synergistically activate transcription of target genes in
hepatocytes upon ER stress; and (7) proinflammatory cyto-
kines induce cleavage of CREBH and activate the APR
and the UPR in the liver in vivo. Our results raise an intriguing
notion that many physiological and pathological processes
that induce ER stress, such as gene mutations that disturb
protein folding, cholesterol or lipid overloading, hyperhomo-
cysteinemia, nutrient deprivation, or infection with patho-
genic organisms (Kaufman, 2002), can induce an inflamma-
tory response through CREBH cleavage.
Our studies also provide insight into ATF6 function. UPR
transcriptional activation was intact in C. elegans deleted in
atf-6 and in mammalian cells with reduced ATF6 (Lee
et al., 2003; Shen et al., 2005), suggesting that ATF6 is
Figure 7. CREBH and ATF6 Bind to a Conserved DNA Sequence Motif Identified in APR Genes
(A) The proposed CREBH/ATF6 binding elements present in the human CRP, murine SAP, human ApoB, and murine ApoB genes.
(B) CREBH binds to the proposed CREBH/ATF6 binding element in promoter of the human CRP gene. The sequence of human CRP probe used for EMSA
is 50-ACTGGCAGCAGGACGTGACCATGGAG-30; the mutant probe is 50-ACTGGCAGCAGACAACTACCATGGAG-30. B-oligo, biotin-labeled DNA probe;
N-oligo, nonlabeled probe; M-oligo, biotin-labeled mutant probe; ‘‘CTL’’ represents NE from COS1 cells transfected with empty vector; ‘‘F’’ represents NE
from COS1 cells expressing CREBH-F; ‘‘N’’ represents NE from COS1 cells expressing CREBH-N.
(C) CREBH and ATF6 bind to the same element in the human CRP gene. The upper panel shows detection of CREBH bound to the human CRP probe by
using an anti-flag antibody. The lower panel shows detection of ATF6 bound to the probe by using an anti-HA antibody. NEs from COS1 cells expressing
CREBH-N or ATF6 p50 were subjected to Western blot analysis as controls (lanes 1 and 9). B-oligo, biotin-labeled DNA probe; M-oligo, biotin-labeled mu-
tant probe; ‘‘CTL’’ represents NE from COS1 cells transfected with empty vector; ‘‘C’’ represents NE from COS1 cells expressing CREBH-N; ‘‘A’’ repre-
sents NE from COS1 cells expressing ATF6 p50; ‘‘C+A’’ represents NE from COS1 cells expressing both CREBH-N and ATF6 p50.
(D) Proposed model for CREBH-mediated signaling pathway.dispensable for UPR signaling and may provide some other
function. Our finding that ATF6 activates promoters of the
APR genes is significant because this is the first evidence
for a physiological role of ATF6 during ER stress. In hepato-
cytes, activated ATF6 can serve as a potent enhancer to
augment CREBH-mediated acute inflammatory response.
ATF6 may represent a general ER stress-activated dimeriza-
tion partner for tissue-specific transcription factors, such as
CREBH, OASIS, and Luman, that are regulated by RIP.
It is now appreciated that inflammation contributes signif-
icantly to the atherosclerotic process (Danesh et al., 2004;
Hansson, 2005) and is associated with proatherogenic
changes in lipoprotein metabolism that include increased
VLDL and reduced HDL cholesterol levels (Khovidhunkitet al., 2000). Recent evidence suggests that plasma CRP
is as an important factor as cholesterol in assessing the
risk of myocardial infarction and may play a proatherogenic
role during the APR (Paul et al., 2004; Nissen et al., 2005;
Ridker et al., 2005). Here we identify a novel set of transcrip-
tion factors CREBH/ATF6 that regulate CRP expression. In-
terestingly, these factors are activated by ER stress, indicat-
ing a possible link between ER stress and associated
pathological increases in CRP. Therefore, the finding that
CREBH regulates CRP expression may have great impact
on understanding the pathogenesis of coronary artery dis-
ease. In addition, our studies using CREBH knockdown
mice reveal that CREBH-mediated signaling is required to
potently induce the APR. Further studies to evaluate theCell 124, 587–599, February 10, 2006 ª2006 Elsevier Inc. 597
requirement of CREBH for more subtle regulation of the APR
genes under different conditions will require the analysis of
CREBH-deleted mice.
In summary, our studies reveal a novel ER stress-
response pathway mediated by CREBH and regulated by
RIP (Figure 7D). Proinflammatory cytokines and/or ER stress
induce expression and cleavage of CREBH in the liver. Acti-
vated ATF6 and CREBH traffic into the nucleus, dimerize,
and synergistically activate transcription of the major APR
genes (Figure 7D). Rational targeting to modulate CREBH
and/or ATF6 cleavage, dimerization, trafficking, or transcrip-
tional activation may generate novel therapeutics that sup-
press or promote activation of the APR in different disease
states. All these notions merit future research efforts on
CREBH/ATF6.
EXPERIMENTAL PROCEDURES
Generation of CREBH Knockdown Mice
Generation of RNA interference transgenic mice was performed as de-
scribed previously (Rubinson et al., 2003). Briefly, vectors that express
hairpin siRNAs under the control of the mouse U6 promoter were con-
structed by inserting pairs of annealed DNA oligonucleotides into the Len-
tiLox3.7 vector (kindly provided by Dr. Luk Van Parijs) between the HpaI
and XhoI restriction sites. The sequence used for CREBH RNAi is: TCGA
GAAAAAAGACATAGCGGCTGGAAAGATCTCTTGAATCTTTCCAGCCG
CTATGTCA. The clones and packaging vectors, including VSVG, RSV-
REV, pMDL g/p RRE, were cotransfected into 293T cells. The superna-
tants containing virus were concentrated by ultracentrifugation. A small
volume of high-titer RNAi lentivirus (approximately 5  106 IU ml1) was
transferred into the perivitelline space of single-cell C57BL/6J mouse em-
bryos through microinjection. The injected single-cell embryos were im-
planted into pseudopregnant recipient mice for generating CREBH
knockdown embryos and pups.
EMSA and DNA-Protein Binding Assay
EMSA analysis was performed by using a Lightshift Chemiluminescent
EMSA kit (PIERCE, Rockford, IL) according to the manufacturer’s instruc-
tions. Reactions were performed using 20 mg NE from COS1 cells trans-
fected with empty vector or vector expressing CREBH and/or ATF6 and
100 fmol biotin-labeled DNA probe. DNA-Protein Binding Assays were
carried out by using streptavidin-coated beads to bind biotinated DNA
probe, which was used to interact with nuclear extract proteins as previ-
ously described (Zhu et al., 2002). The binding reaction was performed by
mixing 600 mg of NE proteins from transfected COS1 cells, 6 mg of biotin-
labeled DNA probe, and 60 ml of streptavidin-coated beads with slurry
(PIERCE, Rockford, IL). The binding proteins were separated by SDS-
PAGE followed by Western blot analysis probed with specific antibodies.
See Supplemental Data for other Experimental Procedures.
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